Assessment of the Validity of the INR System for Patients with Liver ImpairmentMichael J. Kovacs, Moira Cruickshank, Angelina Wong et al.|Thrombosis and Haemostasis|1994Cited by 117
Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trialMichael J. Kovacs, Marc Rodger, Philip S. Wells et al.|BMJ|2021Cited by 105
Successful treatment of heparin induced thrombocytopenia (HIT) with fondaparinuxKevin H.M. Kuo, Michael J. Kovacs|Thrombosis and Haemostasis|2005Cited by 98
Three different chromogenic methods do not give equivalent anti-Xa levels for patients on therapeutic low molecular weight heparin (dalteparin) or unfractionated heparinMichael J. Kovacs, Eleanor Boyle, Karen MacKinnon et al.|Clinical & Laboratory Haematology|1999Cited by 75
Fondaparinux: A potential new therapy for HITKevin H.M. Kuo, Michael J. Kovacs|Hematology|2005Cited by 63